Ukrainian Journal Health of Woman. 2022. 1(158): 34-43; doi 10.15574/HW.2022.158.34
Романенко Т. Г., Есып Н. В.
Национальный университет здравоохранения Украины имени П.Л. Шупика, г. Киев

Для цитирования: Romanenko TG, Yesyp NV. (2022). Modern view on the prevention of obstetric and perinatal complications in pregnant women with allogeneic fetus. Ukrainian Journal Health of Woman. 1(158): 34-43; doi 10.15574/HW.2022.158.34
Статья поступила в редакцию 13.11.2021 г., принята в печать 07.03.2022 г.

Широкое использование вспомогательных репродуктивных технологий обязано стремительному развитию биомедицинской науки. Однако прогресс сталкивается с непрерывным ухудшением репродуктивного здоровья населения, поэтому дефицит знаний на сегодняшний день относительно теоретических и практических аспектов остается значительным. Несмотря на усовершенствование методик манипуляции с донорскими ооцитами и имеющиеся значительные успехи касательно акушерских и перинатальных последствий в случаях беременности с полностью аллогенным плодом, невыясненными остаются реальные фактические данные о частоте возникновения осложнений течения беременности, родов и послеродового периода у данной категории пациенток.
Цель — проанализировать данные по акушерским и перинатальным осложнениям у беременных с аллогенным плодом, а также факторы, способные влиять на них.
Обобщены имеющиеся современные данные по акушерским и перинатальным осложнениям у беременных с аллогенным плодом, проанализированы биологические предпосылки их возникновения, особенности функционирования фетоплацентарного комплекса у таких пациенток, а также освещена тема психологического статуса беременной с аллогенным плодом и потенциальное влияние его на течение беременности, родов и послеродового периода.
Авторы заявляют об отсутствии конфликта интересов.
Ключевые слова: вспомогательные репродуктивные технологии, экстракорпоральное оплодотворение, аллогенный плод, иммунологическая толерантность, донация ооцитов, суррогатное материнство, акушерские осложнения, перинатальные последствия, фетоплацентарный комплекс, психологический статус.

ЛИТЕРАТУРА

1. ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy. (2018). Obstetrics and gynecology. 132 (1): e44-e52. https://doi.org/10.1097/AOG.0000000000002708; PMid:29939940

2. Adams DH, Clark RA, Davies MJ et al. (2016). A meta-analysis of neonatal health outcomes from oocyte donation. Journal of developmental origins of health and disease. 7 (3): 257-272. https://doi.org/10.1017/S2040174415007898; PMid:26611736

3. Applegarth L, Goldberg NC, Cholst I et al. (1995). Families created through ovum donation: a preliminary investigation of obstetrical outcome and psychosocial adjustment. Journal of assisted reproduction and genetics. 12 (9): 574-580. https://doi.org/10.1007/BF02212577; PMid:8580652

4. Bartlett JA. (1991). Psychiatric issues in non-anonymous oocyte donation. Motivations and expectations of women donors and recipients. Psychosomatics. 32 (4): 433-437. https://doi.org/10.1016/S0033-3182(91)72047-1

5. Berntsen S, Larsen EC, la Cour Freiesleben N et al. (2021). Pregnancy outcomes following oocyte donation. Best practice & research. Clinical obstetrics & gynaecology. 70: 81-91. https://doi.org/10.1016/j.bpobgyn.2020.07.008; PMid:32741624

6. Berntsen S, Söderström-Anttila V, Wennerholm UB et al. (2019). The health of children conceived by ART: 'the chicken or the egg?'. Human reproduction update. 25 (2): 137-158. https://doi.org/10.1093/humupd/dmz001; PMid:30753453

7. Blázquez A, García D, Rodríguez A et al. (2016). Is oocyte donation a risk factor for preeclampsia? A systematic review and meta-analysis. Journal of assisted reproduction and genetics. 33 (7): 855-863. https://doi.org/10.1007/s10815-016-0701-9; PMid:27007875 PMCid:PMC4930777

8. Bracewell-Milnes T, Saso S, Bora S et al. (2016). Investigating psychosocial attitudes, motivations and experiences of oocyte donors, recipients and egg sharers: a systematic review. Human reproduction update. 22 (4): 450-465. https://doi.org/10.1093/humupd/dmw006; PMid:27016289

9. Brady P, Brison N, Van Den Bogaert K et al. (2016). Clinical implementation of NIPT — technical and biological challenges. Clinical genetics. 89 (5): 523-530. https://doi.org/10.1111/cge.12598; PMid:25867715

10. Carolan M. (2003). Late motherhood: the experience of parturition for first time mothers aged over 35 years. Australian journal of midwifery: professional journal of the Australian College of Midwives Incorporated. 16 (2): 17-20. https://doi.org/10.1016/S1031-170X(03)80004-1

11. Casale M, Carlqvist A. (2021). Is social support related to better mental health, treatment continuation and success rates among individuals undergoing in-vitro fertilization? Systematic review and meta-analysis protocol. PloS one. 16 (6): e0252492. https://doi.org/10.1371/journal.pone.0252492; PMid:34061903 PMCid:PMC8168841

12. Chervenak FA, McCullough LB. (2021). Ethics and Professionalism Guidelines for Obstetrics and Gynecology. London: International Federation of Gynecology and Obstetrics: 289.

13. Clua E, Meler E, Rodríguez D et al. (2016). Obstetric and perinatal complications in an oocyte donation programme. Is it time to limit the number of embryos to transfer?. Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology. 32 (4): 267-271. https://doi.org/10.3109/09513590.2015.1111330; PMid:26490075

14. Coughlan C, Ledger W, Wang Q et al. (2014). Recurrent implantation failure: definition and management. Reproductive biomedicine online. 28 (1): 14-38. https://doi.org/10.1016/j.rbmo.2013.08.011; PMid:24269084

15. Dar S, Lazer T, Swanson S et al. (2015). Assisted reproduction involving gestational surrogacy: an analysis of the medical, psychosocial and legal issues: experience from a large surrogacy program. Human reproduction (Oxford, England). 30 (2): 345-352. https://doi.org/10.1093/humrep/deu333; PMid:25518975

16. De Geyter C, Calhaz-Jorge C, Kupka MS, Wyns C, Mocanu E, Motrenko T, Scaravelli G, Smeenk J, Vidakovic S, Goossens V & European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE). (2020). ART in Europe, 2015: results generated from European registries by ESHRE. Human reproduction open. 1: hoz038. https://doi.org/10.1093/hropen/hoz038; PMid:32123753 PMCid:PMC7038942

17. Edelmann RJ, Connolly KJ. (2000). Gender differences in response to infertility and infertility investigations: Real or illusory. British Journal of Health Psychology. 5 (4): 365-375. https://doi.org/10.1348/135910700168982

18. Eichelberger KY. (2019). The association between assisted reproduction technology (ART) and abnormal placentation. BJOG. 126 (2): 219.  https://doi.org/10.1111/1471-0528.15262; PMid:29900643

19. Elenis E, Sydsjö G, Skalkidou A et al. (2016). Neonatal outcomes in pregnancies resulting from oocyte donation: a cohort study in Sweden. BMC pediatrics. 16 (1): 170. https://doi.org/10.1186/s12887-016-0708-5; PMid:27769207 PMCid:PMC5073900

20. Frederiksen Y, Farver-Vestergaard I, Skovgård NG et al. (2015). Efficacy of psychosocial interventions for psychological and pregnancy outcomes in infertile women and men: a systematic review and meta-analysis. BMJ open. 5 (1): e006592. https://doi.org/10.1136/bmjopen-2014-006592; PMid:25631310 PMCid:PMC4316425

21. Gameiro S, Boivin J, Dancet E et al. (2015). ESHRE guideline: routine psychosocial care in infertility and medically assisted reproduction — a guide for fertility staff. Human reproduction (Oxford, England). 30 (11): 2476-2485. https://doi.org/10.1093/humrep/dev177; PMid:26345684

22. Geisler M, Meaney S, Waterstone J et al. (2020). Stress and the impact on the outcome of medically assisted reproduction. European journal of obstetrics, gynecology, and reproductive biology. 248: 187-192. https://doi.org/10.1016/j.ejogrb.2020.03.006; PMid:32240891

23. Greenfeld DA. (1997). Does psychological support and counseling reduce the stress experienced by couples involved in assisted reproductive technology? Journal of assisted reproduction and genetics. 14 (4): 186-188. https://doi.org/10.1007/BF02766107; PMid:9130064 PMCid:PMC3454690

24. Hammarberg K, Fisher JRW, Wynter K. (2008). Psychological and social aspects of pregnancy, childbirth and early parenting after assisted conception: a systematic review. Hum. Reprod. Update. 14 (5): 395-414. https://doi.org/10.1093/humupd/dmn030; PMid:18653674

25. Hiby SE, Regan L, Lo W et al. (2008). Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Human reproduction (Oxford, England). 23 (4): 972-976. https://doi.org/10.1093/humrep/den011; PMid:18263639

26. Hiby SE, Walker JJ, O'shaughnessy KM et al. (2004). Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. The Journal of experimental medicine. 200 (8): 957-965. https://doi.org/10.1084/jem.20041214; PMid:15477349 PMCid:PMC2211839

27. Johnsen GM, Størvold GL, Drabbels J et al. (2018). The combination of maternal KIR-B and fetal HLA-C2 is associated with decidua basalis acute atherosis in pregnancies with preeclampsia. Journal of reproductive immunology. 129: 23-29. https://doi.org/10.1016/j.jri.2018.07.005; PMid:30055414

28. Jones BP, Ranaei-Zamani N, Vali S et al. (2021). Options for acquiring motherhood in absolute uterine factor infertility; adoption, surrogacy and uterine transplantation. The obstetrician & gynaecologist: the journal for continuing professional development from the Royal College of Obstetricians & Gynaecologists. 23 (2): 138-147. https://doi.org/10.1111/tog.12729; PMid:34248417 PMCid:PMC8252631

29. Klock SC, Covington SN. (2015). Results of the Minnesota Multiphasic Personality Inventory-2 among gestational surrogacy candidates. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 130 (3): 257-260. https://doi.org/10.1016/j.ijgo.2015.03.030; PMid:25980365

30. Krieg SA, Henne MB, Westphal LM. (2008). Obstetric outcomes in donor oocyte pregnancies compared with advanced maternal age in in vitro fertilization pregnancies. Fertility and sterility. 90 (1): 65-70. https://doi.org/10.1016/j.fertnstert.2007.06.014; PMid:17727845

31. Lashley LE, Haasnoot GW, Spruyt-Gerritse M et al. (2015). Selective advantage of HLA matching in successful uncomplicated oocyte donation pregnancies. Journal of reproductive immunology. 112: 29-33. https://doi.org/10.1016/j.jri.2015.05.006; PMid:26232147

32. Luke B, Brown MB, Wantman E et al. (2019). Risk of severe maternal morbidity by maternal fertility status: a US study in 8 states. American journal of obstetrics and gynecology. 220 (2): 195.e1-195.e12. https://doi.org/10.1016/j.ajog.2018.10.012; PMid:30321527

33. Mascarenhas M, Sunkara SK, Antonisamy B et al. (2017). Higher risk of preterm birth and low birth weight following oocyte donation: A systematic review and meta-analysis. European journal of obstetrics, gynecology, and reproductive biology. 218: 60-67. https://doi.org/10.1016/j.ejogrb.2017.09.015; PMid:28942045

34. Massarotti C, Gentile G, Ferreccio C et al. (2019). Impact of infertility and infertility treatments on quality of life and levels of anxiety and depression in women undergoing in vitro fertilization. Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology. 35 (6): 485-489. https://doi.org/10.1080/09513590.2018.1540575; PMid:30612477

35. Meldrum DR. (2016). Lightening the burden of care in assisted reproductive technology. Fertil Steril. 105 (5): 1144-1145. https://doi.org/10.1016/j.fertnstert.2016.03.016; PMid:26989047

36. Melnick AP, Rosenwaks Z. (2018). Oocyte donation: insights gleaned and future challenges. Fertility and sterility. 110 (6): 988-993. https://doi.org/10.1016/j.fertnstert.2018.09.021; PMid:30396566

37. Modest AM, Johnson KM, Karumanchi SA et al. (2019). Risk of ischemic placental disease is increased following in vitro fertilization with oocyte donation: a retrospective cohort study. Journal of assisted reproduction and genetics. 36 (9): 1917-1926. https://doi.org/10.1007/s10815-019-01545-3; PMid:31359234 PMCid:PMC6730979

38. Monga M, Alexandrescu B, Katz SE et al. (2004). Impact of infertility on quality of life, marital adjustment, and sexual function. Urology. 63 (1): 126-130. https://doi.org/10.1016/j.urology.2003.09.015; PMid:14751363

39. Moreno-Sepulveda J, Checa MA. (2019). Risk of adverse perinatal outcomes after oocyte donation: a systematic review and meta-analysis. Journal of assisted reproduction and genetics. 36 (10): 2017-2037. https://doi.org/10.1007/s10815-019-01552-4; PMid:31440959 PMCid:PMC6823473

40. Nejdet S, Bergh C, Källén K et al. (2016). High risks of maternal and perinatal complications in singletons born after oocyte donation. Acta obstetricia et gynecologica Scandinavica. 95 (8): 879-886. https://doi.org/10.1111/aogs.12904; PMid:27060438

41. Nilsson LL, Djurisic S, Hviid TV. (2014). Controlling the Immunological Crosstalk during Conception and Pregnancy: HLA-G in Reproduction. Frontiers in immunology. 5: 198. https://doi.org/10.3389/fimmu.2014.00198; PMid:24860568 PMCid:PMC4026753

42. Osaikhuwuomwan JA, Aziken ME. (2021). Pregnancy in Older Women: Analysis of Outcomes in Pregnancies from Donor oocyte In- vitro Fertilization. Journal of human reproductive sciences. 14 (3): 300-306. https://doi.org/10.4103/jhrs.jhrs_209_20; PMid:34759621 PMCid:PMC8527082

43. Papúchová H, Meissner TB, Li Q et al. (2019). The Dual Role of HLA-C in Tolerance and Immunity at the Maternal-Fetal Interface. Frontiers in immunology. 10: 2730. https://doi.org/10.3389/fimmu.2019.02730; PMid:31921098 PMCid:PMC6913657

44. Practice Committee of the American Society for Reproductive Medicine and the Practice Committee for the Society for Assisted Reproductive Technology. (2021). Guidance regarding gamete and embryo donation. Fertility and sterility. 115 (6): 1395-1410. https://doi.org/10.1016/j.fertnstert.2021.01.045; PMid:33838871

45. Qin J, Liu X, Sheng X et al. (2016). Assisted reproductive technology and the risk of pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies: a meta-analysis of cohort studies. Fertility and sterility. 105 (1): 73-85.e856. https://doi.org/10.1016/j.fertnstert.2015.09.007; PMid:26453266

46. Rizzello F, Coccia ME, Fatini C et al. (2020). Comorbidities, risk factors and maternal/perinatal outcomes in oocyte donation pregnancies. Reproductive biomedicine online. 41 (2): 309-315. https://doi.org/10.1016/j.rbmo.2020.04.020; PMid:32576492

47. Rodriguez-Wallberg KA, Berger AS, Fagerberg A et al. (2019). Increased incidence of obstetric and perinatal complications in pregnancies achieved using donor oocytes and single embryo transfer in young and healthy women. A prospective hospital-based matched cohort study. Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology. 35 (4): 314-319. https://doi.org/10.1080/09513590.2018.1528577; PMid:30626251

48. Rouas-Freiss N, Moreau P, LeMaoult J et al. (2021). Role of the HLA-G immune checkpoint molecule in pregnancy. Human Immunology. 82 (5): 353-361. https://doi.org/10.1016/j.humimm.2021.01.003; PMid:33745758

49. San Lazaro Campillo I, Meaney S, Corcoran P et al. (2019). Risk factors for miscarriage among women attending an early pregnancy assessment unit (EPAU): a prospective cohort study. Irish journal of medical science. 188 (3): 903-912. https://doi.org/10.1007/s11845-018-1955-2; PMid:30607825

50. Shah A, Parisaei M, Garner J. (2019). Obstetric Complications of Donor Egg Conception Pregnancies. Journal of obstetrics and gynaecology of India. 69 (5): 395-398. https://doi.org/10.1007/s13224-019-01211-9; PMid:31598040 PMCid:PMC6765033

51. Simopoulou M, Sfakianoudis K, Tsioulou P et al. (2018). Risks in Surrogacy Considering the Embryo: From the Preimplantation to the Gestational and Neonatal Period. BioMed research international: 6287507. https://doi.org/10.1155/2018/6287507; PMid:30112409 PMCid:PMC6077588

52. Smith NK, Madeira J, Millard HR. (2015). Sexual function and fertility quality of life in women using in vitro fertilization. The journal of sexual medicine. 12 (4): 985-993. https://doi.org/10.1111/jsm.12824; PMid:25639162

53. Söderström-Anttila V, Wennerholm UB, Loft A et al. (2016). Surrogacy: outcomes for surrogate mothers, children and the resulting families-a systematic review. Human reproduction update. 22 (2): 260-276. https://doi.org/10.1093/humupd/dmv046; PMid:26454266

54. Tan CY, Ho JF, Chong YS et al. (2008). Paternal contribution of HLA-G*0106 significantly increases risk for preeclampsia in multigravid pregnancies. Mol Hum Reprod. 14 (5): 317-324. https://doi.org/10.1093/molehr/gan013; PMid:18353802

55. Tilburgs T, Scherjon SA, van der Mast BJ et al. (2009). Fetal-maternal HLA-C mismatch is associated with decidual T cell activation and induction of functional T regulatory cells. Journal of Reproductive Immunology. 82 (2): 148-157. https://doi.org/10.1016/j.jri.2009.05.003; PMid:19631389

56. Van Bentem K, Lashley E, Bos M et al. (2019). Relating the number of human leucocytes antigen mismatches to pregnancy complications in oocyte donation pregnancies: study protocol for a prospective multicentre cohort study (DONOR study). BMJ open. 9 (7): e027469. https://doi.org/10.1136/bmjopen-2018-027469; PMid:31345965 PMCid:PMC6661658

57. Vercammen MJ, Verloes A, Van de Velde H et al. (2008). Accuracy of soluble human leukocyte antigen-G for predicting pregnancy among women undergoing infertility treatment: meta-analysis. Human reproduction update. 14 (3): 209-218. https://doi.org/10.1093/humupd/dmn007; PMid:18390888

58. Vermey BG, Buchanan A, Chambers GM et al. (2019). Are singleton pregnancies after assisted reproduction technology (ART) associated with a higher risk of placental anomalies compared with non-ART singleton pregnancies? A systematic review and meta-analysis. BJOG: an international journal of obstetrics and gynaecology. 126 (2): 209-218. https://doi.org/10.1111/1471-0528.15227; PMid:29740927

59. Wedenoja S, Yoshihara M, Teder H et al. (2020). Fetal HLA-G mediated immune tolerance and interferon response in preeclampsia. EbioMedicine. 59: 102872. https://doi.org/10.1016/j.ebiom.2020.102872; PMid:32680723 PMCid:PMC7502669

60. Wilczyński JR. (2006). Immunological analogy between allograft rejection, recurrent abortion and pre-eclampsia — the same basic mechanism? Human immunology. 67 (7): 492-511. https://doi.org/10.1016/j.humimm.2006.04.007; PMid:16829304

61. Woo I, Hindoyan R, Landay M et al. (2017). Perinatal outcomes after natural conception versus in vitro fertilization (IVF) in gestational surrogates: a model to evaluate IVF treatment versus maternal effects. Fertility and sterility. 108 (6): 993-998. https://doi.org/10.1016/j.fertnstert.2017.09.014; PMid:29202976

62. Yadav V, Bakolia P, Malhotra N et al. (2018). Comparison of Obstetric Outcomes of Pregnancies after Donor-Oocyte In vitro Fertilization and Self-Oocyte In vitro Fertilization: A Retrospective Cohort Study. Journal of human reproductive sciences. 11 (4): 370-375. https://doi.org/10.4103/jhrs.JHRS_115_17; PMid:30787523 PMCid:PMC6333036

63. Yang X, Yang Y, Yuan Y et al. (2020). The Roles of Uterine Natural Killer (NK) Cells and KIR/HLA-C Combination in the Development of Preeclampsia: A Systematic Review. BioMed research international. 2020: 4808072. https://doi.org/10.1155/2020/4808072; PMid:32309433 PMCid:PMC7149372